Cargando…

Genetic Counselling, BRCA1/2 Status and Clinico-pathologic Characteristics of Patients with Ovarian Cancer before 50 Years of Age

BACKGROUND: In Slovenia like in other countries, till recently, personal history of epithelial ovarian cancer (EOC) has not been included among indications for genetic counselling. Recent studies reported up to 17% rate of germinal BRCA1/2 mutation (gBRCA1/2m) within the age group under 50 years at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cvelbar, Mirjam, Hocevar, Marko, Novakovic, Srdjan, Stegel, Vida, Perhavec, Andraz, Krajc, Mateja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter Open 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514659/ https://www.ncbi.nlm.nih.gov/pubmed/28740454 http://dx.doi.org/10.1515/raon-2017-0013

Ejemplares similares

Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families
por: NOVAKOVIĆ, SRDJAN, et al.
Publicado: (2012)

The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population
por: Stegel, Vida, et al.
Publicado: (2011)

The Prevalence of Occult Ovarian Cancer in the Series of 155 Consequently Operated High Risk Asymptomatic Patients – Slovenian Population Based Study
por: Gornjec, Andreja, et al.
Publicado: (2020)

Cytology material is equivalent to tumor tissue in determining mutations of BRCA 1/2 genes in patients with tubo-ovarian high grade serous carcinoma
por: Gornjec, Andreja, et al.
Publicado: (2019)

Genetic testing results in Slovenian male breast cancer cohort indicate the BRCA2 7806-2A > G founder variant could be associated with higher male breast cancer risk
por: Strojnik, Ksenija, et al.
Publicado: (2021)

New Approach for Detection of Normal Alternative Splicing Events and Aberrant Spliceogenic Transcripts with Long-Range PCR and Deep RNA Sequencing
por: Dragoš, Vita Šetrajčič, et al.
Publicado: (2021)

Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families
por: Krajc, Mateja, et al.
Publicado: (2008)

Two Novel NF1 Pathogenic Variants Causing the Creation of a New Splice Site in Patients With Neurofibromatosis Type I
por: Setrajcic Dragos, Vita, et al.
Publicado: (2019)

Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing
por: Stegel, Vida, et al.
Publicado: (2022)

Genotyping of BRCA1, BRCA2, p53, CDKN2A, MLH1 and MSH2 genes in a male patient with secondary breast cancer
por: Vodusek, Ana Lina, et al.
Publicado: (2011)

Identification of Spliceogenic Variants beyond Canonical GT-AG Splice Sites in Hereditary Cancer Genes
por: Dragoš, Vita Šetrajčič, et al.
Publicado: (2022)

An interesting case of likely BRCA2 related bilateral breast cancer with metastasis in the fimbrial part of fallopian tube
por: Boltežar, Lučka, et al.
Publicado: (2020)

A Novel Germline MLH1 In-Frame Deletion in a Slovenian Lynch Syndrome Family Associated with Uncommon Isolated PMS2 Loss in Tumor Tissue
por: Klančar, Gašper, et al.
Publicado: (2020)

BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome
por: Blatnik, Ana, et al.
Publicado: (2022)

Reduction of overtreatment without reduction of overdiagnosis in patients with differentiated thyroid cancer: mission impossible
por: Oblak, Tjasa, et al.
Publicado: (2021)

Tumor vaccine composed of C-class CpG oligodeoxynucleotides and irradiated tumor cells induces long-term antitumor immunity
por: Cerkovnik, Petra, et al.
Publicado: (2010)

Completely Resected Stage III Melanoma Controversy - 15 Years of National Tertiary Centre Experience
por: Peric, Barbara, et al.
Publicado: (2020)

KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study
por: Cerne, Jasmina-Ziva, et al.
Publicado: (2012)

Role of specific DNA mutations in the peripheral blood of colorectal cancer patients for the assessment of tumor stage and residual disease following tumor resection
por: Norcic, Gregor, et al.
Publicado: (2016)

Significance of Nuclear Factor - Kappa Beta Activation on Prostate Needle Biopsy Samples in the Evaluation of Gleason Score 6 Prostatic Carcinoma Indolence
por: Zupancic, Marko, et al.
Publicado: (2020)

Breast cancer risk prediction using Tyrer-Cuzick algorithm with an 18-SNPs polygenic risk score in a European population with below-average breast cancer incidence
por: Oblak, Tjaša, et al.
Publicado: (2023)

Correlation of treatment outcome in sanger/RT-qPCR KIT/PDGFRA wild-type metastatic gastrointestinal stromal tumors with next-generation sequencing results: A single-center report
por: Unk, Mojca, et al.
Publicado: (2022)

Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancer
por: Cerne, Jasmina-Ziva, et al.
Publicado: (2011)

Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma
por: Peric, Barbara, et al.
Publicado: (2011)

Mutational spectrum and classification of novel mutations in patients with metastatic gastrointestinal stromal tumours
por: Bombac, Alenka, et al.
Publicado: (2020)

Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families
por: Peric, Barbara, et al.
Publicado: (2008)

Primary localized retroperitoneal sarcomas: report from Slovenian sarcoma referral center
por: Novak, Marko, et al.
Publicado: (2020)

Sentinel Node Biopsy for Conjunctival Melanoma; Single Centre Experience and Review of Current Literature
por: Peric, Barbara, et al.
Publicado: (2021)

Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas
por: Weren, Robbert D.A., et al.
Publicado: (2016)

Does Regular Quality Control Improve the Quality of Surgery in Slovenian Breast Cancer Screening Program?
por: Perhavec, Andraz, et al.
Publicado: (2020)

Leiomyosarcoma of the renal vein: analysis of outcome and prognostic factors in the world case series of 67 patients
por: Novak, Marko, et al.
Publicado: (2016)

Breast cancer risk assessment and risk distribution in 3,491 Slovenian women invited for screening at the age of 50; a population-based cross-sectional study
por: Jarm, Katja, et al.
Publicado: (2023)

Referral, Genetic Counselling, and BRCA Testing in the Manitoba High-Grade Serous Ovarian Cancer Population, 2004–2019
por: Winchar, Kelcey, et al.
Publicado: (2022)

HIRSUTISM: CLINICO-INVESTIGATIVE PROFILE OF 50 INDIAN PATIENTS
por: Sharma, Nand Lal, et al.
Publicado: (2008)

Other cancers in BRCA1 and BRCA2 mutation carriers: implications for counselling and follow up
por: Ponder, B
Publicado: (2000)

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
por: O’Mahony, Denise G., et al.
Publicado: (2023)

Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features
por: Berns, E M J J, et al.
Publicado: (2001)

BRCA1/2 mutation status in patients with metachronous breast and ovarian malignancies: clues towards the implementation of genetic counseling
por: Chao, Angel, et al.
Publicado: (2019)

Selected aspects of genetic counselling for BRCA1 mutation carriers
por: Gronwald, Jacek
Publicado: (2007)

Improved Survival after Breast-Conserving Therapy Compared with Mastectomy in Stage I-IIA Breast Cancer
por: Ratosa, Ivica, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tenuu6hoi32gc3ke1gigjmijhf